Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9401054rdf:typepubmed:Citationlld:pubmed
pubmed-article:9401054lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:9401054lifeskim:mentionsumls-concept:C0162638lld:lifeskim
pubmed-article:9401054lifeskim:mentionsumls-concept:C0132555lld:lifeskim
pubmed-article:9401054lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:9401054lifeskim:mentionsumls-concept:C1314939lld:lifeskim
pubmed-article:9401054lifeskim:mentionsumls-concept:C0441712lld:lifeskim
pubmed-article:9401054pubmed:issue3lld:pubmed
pubmed-article:9401054pubmed:dateCreated1998-1-23lld:pubmed
pubmed-article:9401054pubmed:abstractTextInduction of nitric oxide synthase (iNOS) and production of the toxic metabolite nitric oxide (NO) is one of the interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) regulated effector mechanisms that can lead to apoptosis of haemopoietic progenitor cells. Fas-receptor (Fas-R) expression can be stimulated by IFN-gamma and TNF-alpha. Transactivation of iNOS, and possibly Fas-R promoters, by interferon regulatory factor-1 expressed in response to IFN-gamma may be a part of the iNOS transduction pathway. We investigated whether the effects of Fas-R triggering in haemopoietic cells were mediated by NO. On Western blotting, we observed that Fas-receptor agonist, monoclonal antibody CH11. enhanced expression of iNOS. As shown by the reverse transcription polymerase chain reaction. CH11 also induced iNOS mRNA expression in purified CD34+ cells. To determine whether NO was involved in Fas-mediated apoptosis we inhibited iNOS-catalysed production of NO using anti-sense (AS) oligodeoxynucleotides (ODN) directed against iNOS mRNA. After culture of haemopoietic cells in the presence of AS-ODN, iNOS expression decreased and was no longer enhanced by Fas. This effect was associated with the prevention of Fas-mediated apoptosis, as determined by a DNA fragmentation and terminal deoxynucleotidyl transferase staining. In colony assays, specific AS-oligonucleotides prevented FAS-mediated inhibition of colony formation by total bone marrow and CD34+ progenitor cells. Our data suggest that the inhibitory effects of Fas, including induction of apoptosis, are mediated by effector mechanisms that may be similar to those described for IFN-gamma and TNF-alpha.lld:pubmed
pubmed-article:9401054pubmed:languageenglld:pubmed
pubmed-article:9401054pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9401054pubmed:citationSubsetIMlld:pubmed
pubmed-article:9401054pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9401054pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9401054pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9401054pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9401054pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9401054pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9401054pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9401054pubmed:statusMEDLINElld:pubmed
pubmed-article:9401054pubmed:monthDeclld:pubmed
pubmed-article:9401054pubmed:issn0007-1048lld:pubmed
pubmed-article:9401054pubmed:authorpubmed-author:SatoTTlld:pubmed
pubmed-article:9401054pubmed:authorpubmed-author:RotoliBBlld:pubmed
pubmed-article:9401054pubmed:authorpubmed-author:YoungN SNSlld:pubmed
pubmed-article:9401054pubmed:authorpubmed-author:MaciejewskiJ...lld:pubmed
pubmed-article:9401054pubmed:authorpubmed-author:SelleriCClld:pubmed
pubmed-article:9401054pubmed:authorpubmed-author:RaiolaA MAMlld:pubmed
pubmed-article:9401054pubmed:issnTypePrintlld:pubmed
pubmed-article:9401054pubmed:volume99lld:pubmed
pubmed-article:9401054pubmed:ownerNLMlld:pubmed
pubmed-article:9401054pubmed:authorsCompleteYlld:pubmed
pubmed-article:9401054pubmed:pagination481-9lld:pubmed
pubmed-article:9401054pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9401054pubmed:meshHeadingpubmed-meshheading:9401054-...lld:pubmed
pubmed-article:9401054pubmed:meshHeadingpubmed-meshheading:9401054-...lld:pubmed
pubmed-article:9401054pubmed:meshHeadingpubmed-meshheading:9401054-...lld:pubmed
pubmed-article:9401054pubmed:meshHeadingpubmed-meshheading:9401054-...lld:pubmed
pubmed-article:9401054pubmed:meshHeadingpubmed-meshheading:9401054-...lld:pubmed
pubmed-article:9401054pubmed:meshHeadingpubmed-meshheading:9401054-...lld:pubmed
pubmed-article:9401054pubmed:meshHeadingpubmed-meshheading:9401054-...lld:pubmed
pubmed-article:9401054pubmed:meshHeadingpubmed-meshheading:9401054-...lld:pubmed
pubmed-article:9401054pubmed:meshHeadingpubmed-meshheading:9401054-...lld:pubmed
pubmed-article:9401054pubmed:meshHeadingpubmed-meshheading:9401054-...lld:pubmed
pubmed-article:9401054pubmed:year1997lld:pubmed
pubmed-article:9401054pubmed:articleTitleInduction of nitric oxide synthase is involved in the mechanism of Fas-mediated apoptosis in haemopoietic cells.lld:pubmed
pubmed-article:9401054pubmed:affiliationDivision of Haematology, Federico II University Medical School, Naples, Italy.lld:pubmed
pubmed-article:9401054pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9401054lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9401054lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9401054lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9401054lld:pubmed